U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07547332) titled 'Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC' on April 08.
Brief Summary: This is a prospective, single-arm, investigator-initiated clinical study (IIT) designed to evaluate the efficacy and safety of nab-paclitaxel combined with local radiotherapy for patients with extensive-stage small cell lung cancer (ES-SCLC) whose disease has progressed after first-line treatment.
Small cell lung cancer (SCLC) is an aggressive type of lung cancer, and extensive-stage SCLC (ES-SCLC) refers to its advanced stage. For patients whose cancer progresses after first-line treatment, there are very limited effective second-line and lat...